Ensysce Biosciences (ENSCW) Invested Capital (2017 - 2025)
Ensysce Biosciences (ENSCW) reported Invested Capital of $2.9 million for Q4 2025, down 14.65% year-over-year from $3.4 million in Q4 2024, and up 139.72% quarter-over-quarter from $1.2 million in Q3 2025.
Ensysce Biosciences (ENSCW) Invested Capital (2017 - 2025) Analysis & Trends
Ensysce Biosciences (ENSCW) has 9 years of Invested Capital data on file, last reported at $2.9 million in Q4 2025.
- Invested Capital for Q4 2025 came in at $2.9 million, down 14.65% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.9 million (down 14.65% YoY), and the FY2025 annual result was $2.9 million, down 14.65% from the prior year.
- Invested Capital advanced to $2.9 million in Q4 2025 per ENSCW's latest filing, from $1.2 million in the prior quarter.
- Over five years, Invested Capital peaked at $6.6 million in Q3 2024 and troughed at -$8.2 million in Q4 2021.
- A 5-year average of $442906.8 and a median of $1.2 million in 2023 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2022 and 2024: Invested Capital plunged 1359.15% in 2022, then soared 2344.15% in 2024.
- A 5-year view of Invested Capital shows it stood at -$8.2 million in 2021, then jumped by 50.61% to -$4.0 million in 2022, then soared by 83.84% to -$651267.0 in 2023, then soared by 618.98% to $3.4 million in 2024, then slipped by 14.65% to $2.9 million in 2025.
- Business Quant data shows ENSCW's Invested Capital at $2.9 million in Q4 2025, $1.2 million in Q3 2025, and $3.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Ensysce Biosciences | - | - | - | 2.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.88 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 3.06 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | 3.38 Mn |
| Sep 30, 2024 | 6.58 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 3.42 Mn |
| Dec 31, 2023 | -651,267.00 |
| Sep 30, 2023 | 1.16 Mn |
| Jun 30, 2023 | 3.79 Mn |
| Mar 31, 2023 | -152,424.00 |
| Dec 31, 2022 | -4.03 Mn |
| Sep 30, 2022 | -5.62 Mn |
| Jun 30, 2022 | -797,578.00 |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | -8.16 Mn |
| Sep 30, 2021 | -385,287.00 |
| Jun 30, 2021 | 5.17 Mn |
| Mar 31, 2021 | -7.30 Mn |